c-myb AS ODN

N/A

Report date: 2024/09/23 20:00:34
NME

Base Information

Drug Namec-myb AS ODN
Drug Alias NameN/A
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Oligonucleotide antisense
Mechanisms of Actionc-myb expression inhibitors
TargetsTranscriptional activator Myb
Therapy Area/IndicationsHematologic Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesAbramson Cancer Center at Penn Medicine
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAbramson Cancer Center at Penn Medicine
Active IndicationsN/A
Inactive IndicationsHematologic Neoplasms

Other Information

ATC CodeN/A
Related LinksN/A